Bank of America’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $726K | Buy |
168,534
+35,626
| +27% | +$154K | ﹤0.01% | 4621 |
|
2025
Q1 | $497K | Buy |
132,908
+122,127
| +1,133% | +$457K | ﹤0.01% | 4734 |
|
2024
Q4 | $109K | Sell |
10,781
-4,482
| -29% | -$45.4K | ﹤0.01% | 5481 |
|
2024
Q3 | $190K | Sell |
15,263
-4,649
| -23% | -$57.9K | ﹤0.01% | 5165 |
|
2024
Q2 | $259K | Buy |
19,912
+9,384
| +89% | +$122K | ﹤0.01% | 4946 |
|
2024
Q1 | $238K | Sell |
10,528
-9,902
| -48% | -$224K | ﹤0.01% | 4972 |
|
2023
Q4 | $265K | Sell |
20,430
-3,078
| -13% | -$39.9K | ﹤0.01% | 5018 |
|
2023
Q3 | $473K | Buy |
23,508
+1,079
| +5% | +$21.7K | ﹤0.01% | 4520 |
|
2023
Q2 | $602K | Sell |
22,429
-121,423
| -84% | -$3.26M | ﹤0.01% | 4362 |
|
2023
Q1 | $8.39M | Buy |
143,852
+43,108
| +43% | +$2.52M | ﹤0.01% | 2563 |
|
2022
Q4 | $5.14M | Buy |
100,744
+51,953
| +106% | +$2.65M | ﹤0.01% | 2869 |
|
2022
Q3 | $4M | Buy |
48,791
+16,830
| +53% | +$1.38M | ﹤0.01% | 3023 |
|
2022
Q2 | $2.16M | Sell |
31,961
-42,454
| -57% | -$2.87M | ﹤0.01% | 3655 |
|
2022
Q1 | $8.23M | Buy |
74,415
+57,424
| +338% | +$6.35M | ﹤0.01% | 2653 |
|
2021
Q4 | $1.64M | Buy |
16,991
+1,263
| +8% | +$122K | ﹤0.01% | 4083 |
|
2021
Q3 | $1.37M | Buy |
15,728
+33
| +0.2% | +$2.88K | ﹤0.01% | 4093 |
|
2021
Q2 | $2.43M | Buy |
15,695
+676
| +5% | +$105K | ﹤0.01% | 3597 |
|
2021
Q1 | $2.37M | Buy |
15,019
+3,905
| +35% | +$616K | ﹤0.01% | 3609 |
|
2020
Q4 | $2.58M | Sell |
11,114
-874
| -7% | -$203K | ﹤0.01% | 3209 |
|
2020
Q3 | $2.63M | Buy |
11,988
+2,043
| +21% | +$447K | ﹤0.01% | 3041 |
|
2020
Q2 | $2.83M | Buy |
9,945
+3,325
| +50% | +$945K | ﹤0.01% | 2982 |
|
2020
Q1 | $1.91M | Buy |
6,620
+1,012
| +18% | +$292K | ﹤0.01% | 3119 |
|
2019
Q4 | $1.61M | Buy |
5,608
+1,602
| +40% | +$460K | ﹤0.01% | 3580 |
|
2019
Q3 | $579K | Buy |
4,006
+377
| +10% | +$54.5K | ﹤0.01% | 4256 |
|
2019
Q2 | $326K | Sell |
3,629
-1,166
| -24% | -$105K | ﹤0.01% | 4630 |
|
2019
Q1 | $421K | Buy |
4,795
+833
| +21% | +$73.1K | ﹤0.01% | 4428 |
|
2018
Q4 | $557K | Sell |
3,962
-754
| -16% | -$106K | ﹤0.01% | 4206 |
|
2018
Q3 | $1.21M | Sell |
4,716
-381
| -7% | -$97.4K | ﹤0.01% | 3754 |
|
2018
Q2 | $1.3M | Buy |
5,097
+2,104
| +70% | +$536K | ﹤0.01% | 3697 |
|
2018
Q1 | $602K | Buy |
2,993
+156
| +5% | +$31.4K | ﹤0.01% | 4062 |
|
2017
Q4 | $408K | Sell |
2,837
-256
| -8% | -$36.8K | ﹤0.01% | 4332 |
|
2017
Q3 | $510K | Buy |
3,093
+120
| +4% | +$19.8K | ﹤0.01% | 4210 |
|
2017
Q2 | $403K | Sell |
2,973
-102
| -3% | -$13.8K | ﹤0.01% | 4307 |
|
2017
Q1 | $592K | Buy |
3,075
+20
| +0.7% | +$3.85K | ﹤0.01% | 4116 |
|
2016
Q4 | $431K | Buy |
3,055
+1
| +0% | +$141 | ﹤0.01% | 4191 |
|
2016
Q3 | $446K | Sell |
3,054
-766
| -20% | -$112K | ﹤0.01% | 4019 |
|
2016
Q2 | $385K | Sell |
3,820
-25
| -0.7% | -$2.52K | ﹤0.01% | 4098 |
|
2016
Q1 | $514K | Sell |
3,845
-1,021
| -21% | -$136K | ﹤0.01% | 3857 |
|
2015
Q4 | $967K | Sell |
4,866
-253
| -5% | -$50.3K | ﹤0.01% | 3564 |
|
2015
Q3 | $809K | Sell |
5,119
-3,238
| -39% | -$512K | ﹤0.01% | 3648 |
|
2015
Q2 | $3.41M | Sell |
8,357
-1,562
| -16% | -$638K | ﹤0.01% | 2311 |
|
2015
Q1 | $4.56M | Buy |
9,919
+7,335
| +284% | +$3.37M | ﹤0.01% | 2028 |
|
2014
Q4 | $1.45M | Buy |
2,584
+1,469
| +132% | +$825K | ﹤0.01% | 2848 |
|
2014
Q3 | $584K | Buy |
1,115
+53
| +5% | +$27.8K | ﹤0.01% | 3390 |
|
2014
Q2 | $741K | Sell |
1,062
-534
| -33% | -$373K | ﹤0.01% | 3242 |
|
2014
Q1 | $739K | Buy |
1,596
+1,519
| +1,973% | +$703K | ﹤0.01% | 3271 |
|
2013
Q4 | $26K | Buy |
+77
| New | +$26K | ﹤0.01% | 5111 |
|